Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
about
6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosynthesesPET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models.Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers.Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial.Fasting Enhances the Contrast of Bone Metastatic Lesions in 18F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases.[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors.Amino Acid Metabolism as a Target for Breast Cancer ImagingRole of PET imaging for biochemical recurrence following primary treatment for prostate cancer
P2860
Q26991479-4243404A-06A0-4568-AE75-0AF747D6F6FBQ33836426-E582DE65-98B5-41A6-8064-C9651456627AQ34451031-96F5302B-115D-4C6F-8A7F-F5BAE8AB2780Q34473613-AAA4B60A-AF9D-40BA-8AEF-E394619D80DFQ35764792-0EE0BB77-87A2-46EC-9BF1-C169B30B5270Q36045175-447AC09A-A497-468A-AF4C-996E790E79E3Q41026634-2B07B0CD-18E0-4FDB-B5A7-5B119D8EAE87Q42229244-F163637E-DBE0-4078-BE60-0981AE64D7CAQ42362580-49628DA6-FE0D-48D3-B849-3C8D871D757BQ48304602-12CAE59B-DE3C-4B44-ACF8-19CCF4FC7401Q48457964-89960680-DACC-4DB7-B046-2A234B0E057CQ57110643-C23B1435-EB3B-44B5-89A0-A2DEF4F1679EQ58562169-19F0B8DC-88E4-46C8-AC31-3E709A06D655
P2860
Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Differences in transport mecha ...... deoxy-2-[18F]fluoro-D-glucose.
@en
Differences in transport mecha ...... deoxy-2-[18F]fluoro-D-glucose.
@nl
type
label
Differences in transport mecha ...... deoxy-2-[18F]fluoro-D-glucose.
@en
Differences in transport mecha ...... deoxy-2-[18F]fluoro-D-glucose.
@nl
prefLabel
Differences in transport mecha ...... deoxy-2-[18F]fluoro-D-glucose.
@en
Differences in transport mecha ...... deoxy-2-[18F]fluoro-D-glucose.
@nl
P2093
P2860
P1476
Differences in transport mecha ...... deoxy-2-[18F]fluoro-D-glucose.
@en
P2093
Hiroyuki Okudaira
Keiichi Kawai
Mark M Goodman
Masahiro Ono
Shuntaro Oka
Yoshifumi Shirakami
P2860
P2888
P304
P356
10.1007/S11307-013-0693-0
P577
2014-06-01T00:00:00Z